The Specifics of the Stromal and Parenchymal Liver Components of 0–6-month-old Dead Children from HIV-monoinfected Mothers
DOI:
https://doi.org/10.3889/oamjms.2020.4113Keywords:
HIV, Children liver, Liver parenchyma, Liver stromaAbstract
OBJECTIVE: The objective of the study was to determine the specifics of the stromal and parenchymal liver components of 0–6-month-old children from HIV-monoinfected mothers.
METHODS: The morphometric investigation included 84 liver tissue biopsies of 0–6-month-old dead children from HIV-monoinfected mothers. All morphometric parameters of the parenchymal and stromal liver components were calculated using the Avtandilov’s microscopic morphometric grid, which was consisted of 100 equidistant points. It was inserted into the microscope’s ocular tube with a total ×200 microscope magnification. The number of points that were found on the corresponding types of parenchymal and stromal liver components was calculated. In every case, it was selected 10 random microscopic areas and then all data were obtained, calculated, and presented as percentages.
RESULTS: Morphometric parameters of hepatocytes: Mononuclear hepatocytes – 87.3 ± 6.2% (control – 93.5 ± 7.1), two-nuclear hepatocytes – 12.7 ± 1.3% (control – 6.5 ± 1.2), two-/mononuclear hepatocytes coefficient – 0.14 ± 0.01 (control – 0.06 ± 0.01), and hepatocytes with fat vacuoles – 15.6 ± 1.8% (control – 0.5 ± 0.2). Parenchymal and stromal liver components: Parenchyma – 64.3 ± 2.1% (control – 74.2 ± 1.3), stroma (including blood vessels and bile ducts) – 35.7 ± 1.9% (control – 25.8 ± 1.6), and stroma/parenchyma index – 0.55 ± 0.01 (control – 0.34 ± 0.01). Morphometric parameters of all of the liver components: Hepatocytes – 64.3 ± 3.1% (control – 74.2 ± 4.3), portal tracts – 14.9 ± 1.9% (control – 3.1 ± 0.6), central veins – 9.3 ± 1.3 % (control – 9.3 ± 1.4), sinusoids – 8.8 ± 1.1% (control – 10.5 ± 1.3), and bile ducts – 2.7 ± 0.2% (control – 2.9 ± 0.2). Expression level parameters: Fibronectin – 64.8 ± 4.1% (control – 17.3 ± 2.5), collagen Type I – 13.6 ± 1.7% (control – 9.7 ± 1.9), collagen Type III – 15.3 ± 1.4% (control – 10.1 ± 0.9), and collagen Type IV – 6.8 ± 0.2% (control – 5.9 ± 0.2).
CONCLUSIONS: It was established that in the liver of 0–6-month-old dead children from HIV-monoinfected mothers, the parenchymal component of the liver showed the signs of its reduction, increase of regenerative activity of hepatocytes, and fatty degeneration of hepatocytes with a certain sign of reactive steatohepatitis. Furthermore, it was established that the stromal component of the liver of children from HIV-infected mothers showed the signs of its progressive proliferation and collagenization due to increased production and accumulation of fibronectin, Type I, Type III collagens in the stroma of portal tracts and newly formed septa, and the signs of hepatic sinusoid capillarization due to Type IV collagen accumulation in the space of Disse of the hepatic sinusoids.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
UNAIDS. Joint United Nations. Programme on HIV/AIDS. Geneva: UNAIDS; 2018. p. 370.
Stover J, Bollinger L, Izazola JA, Loures L, DeLay P, Ghys PD. What is required to end the AIDS epidemic as a public health threat by 2030? The cost and impact of the fast-track approach. PLoS One. 2016;11:e0154893. https://doi.org/10.1371/journal. pone.0154893 PMid:27159260
Ravichandra KR. Opportunistic infections in HIV infected children and its correlation with CD4 count. Int J Contemp Pediatr. 2017;4(5):1743-7. https://doi.org/10.18203/2349-3291.ijcp20173777
Penton PK, Blackard JT. Analysis of HIV quasispecies suggests compartmentalization in the liver. AIDS Res Hum Retroviruses. 2014;30(4):394-402. https://doi.org/10.1089/aid.2013.0146 PMid:24074301
Joshi D, O’Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet. 2011;377(9772):1198-209. https://doi.org/10.1016/ s0140-6736(10)62001-6 PMid:21459211
Avtandilov G.G. The basics of quantitative pathological Anatomy. Moscow. Medicine; 2002. p. 240.
Sterling RK, Smith PG, Brunt EM. Hepatic steatosis in human immunodeficiency virus: A prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. J Clin Gastroenterol. 2013;47(2):182-7. PMid:23059409
Bongiovanni M, Tordato F. Steatohepatitis in HIV-infected subjects: Pathogenesis, clinical impact and implications in clinical management. Curr HIV Res. 2007;5(5):490-8. https:// doi.org/10.2174/157016207781662407 PMid:17896969
Hynes RO. The extracellular matrix: Not just pretty fibrils. Science. 2009;326(5957):1216-9. https://doi.org/10.1126/science.1176009 PMid:19965464
Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209-18. PMid:15690074
Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6(1):425-56. https://doi.org/10.1146/ annurev-pathol-011110-130246 PMid:21073339
Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V. Molecular mechanisms of liver fibrosis in HIV/HCV coinfection. Int J Mol Sci. 2014;15(6);9184-208. https://doi.org/10.3390/ijms15069184 PMid:24865485
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Sergiy O. Sherstiuk, Stanislav I. Panov, Igor V. Belozorov, Tetiana I. Liadova, Oleksij I. Tsivenko (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0